| Evaluation of the effect on heart rate variability of some agents acting at the beta-adrenoceptor using nonlinear scatterplot and sequence methods. | |
| | |
MedLine Citation:
|
PMID: 9926274 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There is evidence that the processes regulating heart rate variability (HRV) reflect nonlinear complexity and show "chaotic" determinism. Data analyses using nonlinear methods may therefore reveal patterns not apparent with the standard methods for HRV analysis. We have consequently used two nonlinear methods, the Poincaré plot (scatterplot) and cardiac sequence (quadrant) analysis, in addition to the standard time-domain summary statistics, during a normal volunteer investigation of the effects on HRV of some agents acting at the cardiac beta-adrenoceptor. Under double-blind and randomized conditions (Latin square design), 25 normal volunteers received placebo, salbutamol 8 mg (beta 2-adrenoceptor partial agonist), pindolol 10 mg (beta 2-adrenoceptor partial agonist), or atenolol 50 mg (beta 1-adrenoceptor antagonist). Single oral doses of medication (at weekly intervals) were administered at 22:30 hours, with sleeping heart rates recorded overnight. The long-term (SDNN, SDANN) and short-term (rMSSD) time-domain summary statistics were reduced by salbutamol 8 mg and increased by atenolol 50 mg compared with placebo. The reductions in both SDNN and SDANN were greater after salbutamol 8 mg compared with pindolol 10 mg. The reduced HRV after pindolol 10 mg differed from the increased HRV following atenolol 50 mg. The Poincaré plot, constructed by plotting each RR interval against the preceding RR interval, was measured using a reproducible computerized method. Scatterplot length and area were reduced by salbutamol 8 mg and increased by atenolol 50 mg compared with placebo; scatterplot length and area were lower after pindolol 10 mg compared with atenolol 50 mg. Geometric analysis of the scatterplots allowed width assessment (i.e., dispersion) at fixed RR intervals. At the higher percentiles (i.e., 90% of scatterplot length: low HR), salbutamol 8 mg reduced and atenolol 50 mg increased dispersion; at lower percentiles (i.e., 10%, 25%, and 50% length), atenolol 50 mg and pindolol 10 mg increased dispersion compared with placebo and salbutamol 8 mg. Cardiac sequence analysis (differences between three adjacent beats; delta RR vs. delta RRn + 1) was used to assess the short-term patterns of cardiac acceleration and deceleration. Four patterns were identified: +/+ (a lengthening sequencing), +/- or -/+ (balanced sequences), and finally -/- (a shortening sequence). Cardiac acceleration episodes (i.e., number of times delta RR and delta RRn + 1 were both changed) were increased in quadrants -/- and +/+ following pindolol 10 mg and salbutamol 8 mg; the beat-to-beat difference (delta RRn + 1) was reduced after salbutamol 8 mg compared with the three other groups. These results demonstrated a shift towards sympathetic dominance (beta-adrenoceptor partial agonist salbutamol 8 mg) or parasympathetic dominance (beta 1-adrenoceptor antagonist atenolol 50 mg); pindolol 10 mg exhibited HR-dependent effects, reducing HRV at low but increasing variability at high prevailing heart rates. These nonlinear methods appear to be valuable tools to investigate HRV in health and to study the implications of perturbation of HRV with drug therapy in disease states. |
| | |
Authors:
|
B Silke; J G Riddell |
Related Documents
:
|
7259364 - Influence of propranolol and acebutolol on isoprenaline-induced changes in heart rate a... 6146344 - Beta-adrenoceptor blocker pharmacokinetics and the oral contraceptive pill. 6104634 - Clinical-pharmacological evaluation of a new beta blocker, gyki-41099 (tobanum). 2546784 - Comparison of beta 1- and beta 2-adrenoceptor effects on gastric emptying of a fat meal... 20084594 - radiation exposure of children in pediatric radiology part 8: radiation doses during th... 3287354 - Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy Volume: 12 ISSN: 0920-3206 ISO Abbreviation: Cardiovasc Drugs Ther Publication Date: 1998 Oct |
Date Detail:
|
Created Date: 1999-03-30 Completed Date: 1999-03-30 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8712220 Medline TA: Cardiovasc Drugs Ther Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 439-48 Citation Subset: IM |
Affiliation:
|
Whitla Division of Medicine, Queen's University of Belfast, Ireland. b.silke@qub.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Agonists
/
therapeutic use* Adrenergic beta-Antagonists / therapeutic use* Albuterol / therapeutic use Atenolol / therapeutic use Double-Blind Method Evaluation Studies as Topic Heart Rate / drug effects* Humans Male Nonlinear Dynamics Pindolol / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Agonists; 0/Adrenergic beta-Antagonists; 13523-86-9/Pindolol; 18559-94-9/Albuterol; 29122-68-7/Atenolol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Gallopamil activity on asynergic viable myocardium in acute myocardial infarction: insights on stunn...
Next Document: Combination of a calcium antagonist, verapamil, with an angiotensin converting enzyme inhibitor, tra...